Influence of the aqueous film coating process on the properties and stability of tablets containing a moisture-labile drugThe influence of excipients on the stability of the moisture sensitive drugs aspirin and niacinamide: comparison of tablets containing lactose monohydrate with tablets containing anhydrous lactoseDrug-excipient compatibility testing using a high-throughput approach and statistical designFormation of oligonucleotide adducts in pharmaceutical formulationsTopical liposomal gel of idoxuridine for the treatment of herpes simplex: pharmaceutical and clinical implicationsFormation of Oligonucleotide Adducts in Pharmaceutical FormulationsTime dependence of elastic recovery for characterization of tableting materials.Ibuprofen penetration enhance by sucrose ester examined by ATR-FTIR in vivo.Solid-state characterization and dissolution properties of Fluvastatin sodium salt hydrates.Communicating tabular data using ORACLE.Elucidation of solution state complexation in wet-granulated oven-dried ibuprofen and beta-cyclodextrin: FT-IR and 1H-NMR studies.Performance of sonication and microfluidization for liquid-liquid emulsification.Lecithin microemulsions in dimethyl ether and propane for the generation of pharmaceutical aerosols containing polar solutes.The relationship between structures and in vitro properties of a polyanhydride implant containing gentamicin sulfate.Drug release from film-coated chlorpheniramine maleate nonpareil beads: water influx and development of a new drug release model.Improving tablet coating robustness by selecting critical process parameters from retrospective data.Ion pair formation as a possible mechanism for the enhancement effect of lauric acid on the transdermal permeation of ondansetron.Comparison of spray congealing and melt emulsification methods for the incorporation of the water-soluble salbutamol sulphate in lipid microparticles.Design and evaluation of mucoadhesive oral films containing sodium hyaluronate using multivariate data analysis.Synthesis of surface-modified TREN-cored PAMAM dendrimers and their effects on the solubility of sulfamethoxazole (SMZ) as an analog antibiotic drug.Design of salbutamol EOP tablets from pharmacokinetics parameters.The influence of thermal treatment and type of insoluble poly(meth)acrylates on dissolution behavior of very soluble drug from hypromellose matrix tablets evaluated by multivariate data analysis.High-efficient nano-carrier gel systems for testosterone propionate skin delivery.The interaction between oxytetracycline and divalent metal ions in aqueous and mixed solvent systems.Content-based image retrieval: a new promising technique in powder technology.Lecithin inverse microemulsions for the pulmonary delivery of polar compounds utilizing dimethylether and propane as propellants.Preparation, characterization, and in vitro evaluation of 1- and 4-month controlled release orntide PLA and PLGA microspheres.Characterization of the sucrose/glycine/water system by differential scanning calorimetry and freeze-drying microscopy.Formulation and evaluation of albuterol metered dose inhalers containing tetrafluoroethane (P134a), a non-CFC propellant.A logical stepwise approach to laser diffraction particle size distribution analysis methods development and validation.Micellization and solubilization behavior of sucrose laurate, a new pharmaceutical excipient.Studies on the influence of pH and pancreatin on 13C-formaldehyde-induced gelatin cross-links using nuclear magnetic resonance.Differences in the mechanical strength of dried microcrystalline cellulose pellets are not due to significant changes in the degree of hydrogen bonding.Solubility enhancement of a bisnaphthalimide tumoricidal agent, DMP 840, through complexation.Novel methods of microparticulate production: application to drug delivery.Evaluation of the hydrophobic drug loading characteristics in nanoprecipitated amphiphilic cyclodextrin nanospheres.Identification of physical-chemical variables affecting particle size following precipitation using a supercritical fluid.Bulk characterization of pharmaceutical powders by low-pressure compression II: effect of method settings and particle size.Manufacture, characterization, and pharmacodynamic evaluation of engineered ipratropium bromide particles.Effects of enantiomer and isomer permeation enhancers on transdermal delivery of ligustrazine hydrochloride.
P1433
Q28165968-3E40F498-A3DA-4DDB-84C0-9E46DAA2B023Q28185407-6B4E84C0-6C6F-4162-82B3-DB6342DE2757Q28194077-B48234E5-CE21-4B84-B163-A6DE30B4B741Q28253707-494DEB01-BCCD-490B-A059-851909C8B89AQ28285518-3A9131B9-3E3A-4D6E-B907-02EF484B5967Q29998947-5100F77F-F33F-4114-A713-C5E685309F7CQ30321001-1E77A8E2-981A-4F7C-AC68-82E96F07A329Q30392695-0C377ACA-CB99-4962-8FD9-EBA3E34D53D3Q30571916-44BD121A-493D-493B-B7AB-79112E2B1C34Q30606671-F7652A57-E781-4873-9C18-BF7D145978A0Q30657719-133CC2C0-4127-43AC-A66F-C1F7E71FB720Q30682697-78A44101-02B6-45CF-84F9-10BD2D17159FQ30723752-3429404B-D5FB-4CE6-842D-46B19F1708BCQ30791697-1F0E0747-C719-4548-AB66-C012426320D0Q30819694-B1694AF2-326B-4ED5-A2C7-C7019D825AF5Q30960079-91772F6A-3960-47B3-9B22-C3C5754D9894Q30967177-55045D9E-BD88-4784-89F8-420E44E863F2Q31097714-690B39F5-A557-4DD8-AC91-20852A8DF25EQ31107509-C54CD99E-F31E-4586-A423-03FDCB136782Q31119728-8AFBD67B-E034-4EBC-9E5E-83A7FF521FC7Q31142816-8655CF99-BDB2-4CF9-9105-14C4E7288DE4Q31153207-E8A5E3CE-5239-4A9E-97A3-BAF6904ABA39Q31160197-25335945-1B3A-4844-9077-4FA1B9773CA1Q31434684-DA3E4FE7-EFB9-4FBB-81C3-3D5920649BCEQ31711871-49CD5B26-D540-4DC0-8990-5B9AA8E3A52BQ31711888-97E455B3-CB11-49E4-B9D8-1581B1679E93Q31834314-68E19BC4-0608-4BCF-A1ED-1BE412634741Q32057322-EE7F773C-1B74-4492-B692-BDDAD3119605Q32057331-DB99BE5A-D931-4520-80EE-65D444A8F2EAQ32057342-5C93F3F4-D20E-444B-BF88-8B325CDDEE56Q32066997-DBBB88CD-6260-4700-93F4-45E5689C9BEFQ32066999-41EC4314-B615-4179-BD86-5F1F2B0777A4Q32067002-993D7EBB-3ACC-4A12-ADC9-EEACF528B7DFQ32067004-66AFB751-A3ED-4CEB-BB57-5A44A305038DQ32067005-73453148-A8F6-4B71-92F5-A4DF8BBBC5D8Q32072549-6D9307F2-EBE8-48DF-B9A0-96B55C681C71Q33245574-07FB834B-C698-4174-B3B1-BC5F8504639DQ33245575-29D70CB2-DF49-4C05-99B7-B40A6F885AB6Q33253272-B3F166CC-C18B-4ECA-B97E-9F813718B597Q33263470-7E169875-2BD2-49E9-8981-82105A353767
P1433
description
begutachtete wissenschaftliche Zeitschrift
@de
peer-reviewed scientific journal
@en
revista científica
@es
rivista scientifica
@it
vědecký časopis
@cs
wetenschappelijk tijdschrift van Informa
@nl
рецензований науковий журнал
@uk
वैज्ञानिक पत्रिका
@hi
name
Pharmaceutical Development and Technology
@ast
Pharmaceutical Development and Technology
@da
Pharmaceutical Development and Technology
@de
Pharmaceutical Development and Technology
@en
Pharmaceutical Development and Technology
@es
Pharmaceutical Development and Technology
@fi
Pharmaceutical Development and Technology
@fr
Pharmaceutical Development and Technology
@it
Pharmaceutical Development and Technology
@nb
Pharmaceutical Development and Technology
@nl
type
label
Pharmaceutical Development and Technology
@ast
Pharmaceutical Development and Technology
@da
Pharmaceutical Development and Technology
@de
Pharmaceutical Development and Technology
@en
Pharmaceutical Development and Technology
@es
Pharmaceutical Development and Technology
@fi
Pharmaceutical Development and Technology
@fr
Pharmaceutical Development and Technology
@it
Pharmaceutical Development and Technology
@nb
Pharmaceutical Development and Technology
@nl
prefLabel
Pharmaceutical Development and Technology
@ast
Pharmaceutical Development and Technology
@da
Pharmaceutical Development and Technology
@de
Pharmaceutical Development and Technology
@en
Pharmaceutical Development and Technology
@es
Pharmaceutical Development and Technology
@fi
Pharmaceutical Development and Technology
@fr
Pharmaceutical Development and Technology
@it
Pharmaceutical Development and Technology
@nb
Pharmaceutical Development and Technology
@nl
P243
P3181
P1055
P1058
P1156
P1159
P1160
Pharm. Dev. Technol.
P123
P1250
P1277
P1476
Pharmaceutical Development and Technology
@en
P236
P243
P3181
P407
P571
1984-01-01T00:00:00Z